Otsuka Holdings
4578.T
#750
Rank
NZ$53.88 B
Marketcap
NZ$102.02
Share price
0.21%
Change (1 day)
3.47%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2025 (TTM): NZ$5.22

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is NZ$5.33. In 2024 the company made an earnings per share (EPS) of NZ$6.99 an increase over its 2023 EPS that were of NZ$2.75.

EPS history for Otsuka Holdings from 2009 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$5.22-25.28%
2024NZ$6.99153.9%
2023NZ$2.75-15.71%
2022NZ$3.27-6.18%
2021NZ$3.48-24.1%
2020NZ$4.5922.95%
2019NZ$3.7356.13%
2018NZ$2.39-25.11%
2017NZ$3.1925.99%
2016NZ$2.53-6.37%
2015NZ$2.71
2014N/A-100%
2013NZ$4.0818.06%
2012NZ$3.451.01%
2011NZ$3.4229.07%
2010NZ$2.65-94.47%
2009NZ$47.88